@misc{indiciae42dd7f954b44,
  title = {FSTL3 is a biomarker of poor prognosis and is associated with immunotherapy resistance in ovarian cancer.},
  author = {Chauvin, M. and Tromelin, E. and Roche-Prellezo, J. and Lancia, H. H. and Meinsohn, M.-C. and Coletti, C. and Nguyen, N. M. P. and Lafont, V. and Michaud, H.-A. and Mishra, R. and Gros, L. and Bonnefoy, N. and Pepin, D.},
  year = {2024},
  doi = {10.1101/2024.12.10.627747},
  url = {https://www.biorxiv.org/content/10.1101/2024.12.10.627747v1},
  note = {Source identifier: 10.1101/2024.12.10.627747}
}